Abstract:Background: Hepatitis C (HCV) and many other RNA viruses exist as rapidly mutating quasi-species populations in a single infected host. High throughput characterization of full genome, within-host variants is still not possible despite advances in next generation sequencing. This limitation constrains viral genomic studies that depend on accurate identification of hemi-genome or whole genome, within-host variants, especially those occurring at low frequencies. With the advent of third generation long read sequencing technologies, including Oxford Nanopore Technology (ONT) and PacBio platforms, this problem is potentially surmountable. ONT is particularly attractive in this regard due to the portable nature of the MinION sequencer, which makes real-time sequencing in remote and resource-limited locations possible. However, this technology (termed here 'nanopore sequencing') has a comparatively high technical error rate. The present study aimed to assess the utility, accuracy and cost-effectiveness of nanopore sequencing for HCV genomes. We also introduce a new bioinformatics tool (Nano-Q) to differentiate within-host variants from nanopore sequencing. Results: The Nanopore platform, when the coverage exceeded 300 reads, generated comparable consensus sequences to Illumina sequencing. Using HCV Envelope plasmids (~ 1800 nt) mixed in known proportions, the capacity of nanopore sequencing to reliably identify variants with an abundance as low as 0.1% was demonstrated, provided the autologous reference sequence was available to identify the matching reads. Successful pooling and nanopore sequencing of 52 samples from patients with HCV infection demonstrated its cost effectiveness (AUD$ 43 per sample with nanopore sequencing versus $100 with paired-end short read technology). The Nano-Q tool successfully separated between-host sequences, including those from the same subtype, by bulk sorting and phylogenetic clustering without an autologous reference sequence (using only a subtype-specific generic reference). The pipeline also identified within-host viral variants and their abundance when the parameters were appropriately adjusted. Conclusion: Cost effective HCV whole genome sequencing and within-host variant identification without haplotype reconstruction are potential advantages of nanopore sequencing.

U-CAN-seq: A Universal Competition Assay by Nanopore Sequencing

Validation of an unbiased metagenomic detection assay for RNA viruses in viral transport media and plasma

Broad-Range Virus Detection and Discovery Using Microfluidic PCR Coupled with High-throughput Sequencing

Artifact-Free Quantification and Sequencing of Rare Recombinant Viruses by Using Drop-Based Microfluidics.

Unbiased metagenomic detection of RNA viruses for rapid identification of viral pathogens in clinical samples

Programmable low-cost DNA-based platform for viral RNA detection

An Evaluation of Avian Influenza Virus Whole-Genome Sequencing Approaches Using Nanopore Technology

Automated Library Construction and Analysis for High-Throughput Nanopore Sequencing of SARS-CoV-2

Evaluation of the impact of concentration and extraction methods on the targeted sequencing of human viruses from wastewater

CRISPR-Mediated Profiling of Viral RNA at Single-Nucleotide Resolution

Rapid, Targeted and Culture-Free Viral Infectivity Assay in Drop-Based Microfluidics

Amplification‐Free, Sequencing‐Free, Detection of Viral RNAs with Variant Specification by Discrete Nanocounting

Quantum-Enhanced Detection of Viral cDNA via Luminescence Resonance Energy Transfer Using Upconversion and Gold Nanoparticles

Targeted Virome Sequencing Enhances Unbiased Detection and Genome Assembly of Known and Emerging Viruses—The Example of SARS-CoV-2

A Benchmark of methods for SARS-CoV-2 whole genome sequencing and development of a more sensitive method

Adaptation of Oxford Nanopore technology for hepatitis C whole genome sequencing and identification of within-host viral variants

Analytical Performance of a Novel Nanopore Sequencing for SARS‐CoV‐2 Genomic Surveillance

An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar

Sequencing of SARS-CoV-2 genome using different nanopore chemistries

A Highly Scalable and Rapidly Deployable RNA Extraction-Free COVID-19 Assay by Quantitative Sanger Sequencing

Rapid viral metagenomics using SMART-9N amplification and nanopore sequencing